« Gloria Estefan's Father | Main | Ohio congressman blocks name change »

Irish drugmaker Elan narrows quarter loss

Irish pharmaceutical company Elan Corp.'s first-quarter loss narrowed amid reduced operating expenses.

The company also said it is on track to seek approval for its highly anticipated multiple sclerosis drug, Antegren....

Elan is developing Antegren with Biogen Idec Inc., of Cambridge, Mass. In February, the two companies said they planned to file for approval of Antegren a year ahead of schedule. Biogen Idec already sells the MS drug Avonex.

More here.

May 16, 2004 in antegren , economy, follow the money..., stocks, tysabri | Permalink

Comments